Nymox Pharmaceutical Corporation is a bio pharmaceutical company, has announced its Annual Financial result s for FY-2014.
As per the report the firm Revenues down by 57%, EPS was -#0.13 and Quick Assets were $0.6 Million 100% up.
View the full earnings release here.